Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Subcutaneous Rapid‐acting Insulin Analogues for Diabetic Ketoacidosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435489/all/Subcutaneous_rapid‐acting_insulin_analogues_for_diabetic_ketoacidosis.
Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435489/all/Subcutaneous_rapid‐acting_insulin_analogues_for_diabetic_ketoacidosis. Accessed November 24, 2024.
Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435489/all/Subcutaneous_rapid‐acting_insulin_analogues_for_diabetic_ketoacidosis
Subcutaneous Rapid‐acting Insulin Analogues for Diabetic Ketoacidosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435489/all/Subcutaneous_rapid‐acting_insulin_analogues_for_diabetic_ketoacidosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis
ID - 435489
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435489/all/Subcutaneous_rapid‐acting_insulin_analogues_for_diabetic_ketoacidosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -